Journal of Vaccine Research, 2025, Vol.15, No.1, 23-33 http://medscipublisher.com/index.php/jvr 31 Barsouk A., Aluru J.S., Rawla P., Saginala K., and Barsouk A., 2023, Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma, Medical Sciences, 11(2): 42. https://doi.org/10.3390/medsci11020042 Basukala O., and Banks L., 2021, The not-so-good, the bad and the ugly: HPV E5, E6 and E7 oncoproteins in the orchestration of carcinogenesis, Viruses, 13(10): 1892. https://doi.org/10.3390/v13101892 Beachler D., Weber K., Margolick J., Strickler H., Cranston R., Burk R., Wiley D., Minkoff H., Reddy S., Stammer E., Gillison M., and D’Souza G., 2011, Risk factors for oral HPV infection among a high prevalence population of HIV-positive and At-risk HIV-negative adults, cancer epidemiology, Biomarkers and Prevention, 21: 122-133. https://doi.org/10.1158/1055-9965.EPI-11-0734 Borse V., Konwar A., and Buragohain P., 2020, Oral cancer diagnosis and perspectives in India, Sensors International, 1: 100046. https://doi.org/10.1016/j.sintl.2020.100046 Brouwer A.F., Eisenberg M.C., and Meza R., 2016, Age effects and temporal trends in HPV-related and HPV-unrelated oral cancer in the united states: a multistage carcinogenesis modeling analysis, PLoS One, 11(3): e0151098. https://doi.org/10.1371/journal.pone.0151098 Chabeda A., Yanez R.J.R., Lamprecht R., Meyers A.E., Rybicki E.P., and Hitzeroth I.I., 2017, Therapeutic vaccines for high-risk HPV-associated diseases, Papillomavirus Research, 5: 46-58. https://doi.org/10.1016/j.pvr.2017.12.006 D’Souza G., McNeel T.S., and Fakhry C., 2017, Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer, Annals of Oncology, 28: 3065-3069. https://doi.org/10.1093/annonc/mdx535 Dust K., Carpenter M., Chen J.C., Grant C., McCorrister S., Westmacott G.R., and Severini A., 2022, Human papillomavirus 16 E6 and E7 oncoproteins alter the abundance of proteins associated with DNA damage response, immune signaling and epidermal differentiation, Viruses, 14(8): 1764. https://doi.org/10.3390/v14081764 Estêvão D., Costa N., Da Costa R.M., and Medeiros R., 2019, Hallmarks of HPV carcinogenesis: the role of E6, E7 and E5 oncoproteins in cellular malignancy, Biochimica et biophysica acta, Gene Regulatory Mechanisms, 1862(2): 153-162. https://doi.org/10.1016/j.bbagrm.2019.01.001 Fernandes Q., Therachiyil L., Younis S.M., Dermime S., and Moustafa A.A., 2025, Oncoproteins E6/E7 of the human papillomavirus types 16 and 18 synergize in modulating oncogenes and tumor suppressor proteins in colorectal cancer, Expert Review of Proteomics, 22(2): 71-84. https://doi.org/10.1080/14789450.2025.2455104 Gillison M.L., 2008, Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination, The Journal of Adolescent Health, 43(4 Suppl): S52-S60. https://doi.org/10.1016/j.jadohealth.2008.07.0022 Gillison M.L., Akagi K., Xiao W.H., Jiang B., Pickard R., Li J., Swanson B., Agrawal A.D., Zucker M., Stache-Crain B., Emde A., Geiger H.M., Robine N., Coombes K., and Symer D.E., 2018, Human papillomavirus and the landscape of secondary genetic alterations in oral cancers, Genome Research, 29(1): 1-17. https://doi.org/10.1101/gr.241141.118 Giuliano A.R., Palefsky J.M., Goldstone S., Moreira E.D., Jr, Penny M.E., Aranda C., Vardas E., Moi H., Jessen H., Hillman R., Chang Y.H., Ferris D., Rouleau D., Bryan J., Marshall J.B., Vuocolo S., Barr E., Radley D., Haupt R.M., Guris D., 2011, Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males, N. Engl. J. Med. 364(5): 401–411. https://doi.org/10.1056/NEJMoa0909537 Hancock G., Hellner K., and Dorrell L., 2017, Therapeutic HPV vaccines, best practice and research, Clinical Obstetrics and Gynaecology, 47: 59-72. https://doi.org/10.1016/j.bpobgyn.2017.09.008 Harper D.M., and Gorin S.S., 2020, HPV vaccination bridges to HPV screening, Eclinicalmedicine, 23: 100435-100435. https://doi.org/10.1016/j.eclinm.2020.100435 Ji T., Liu Y.C., Li Y.T., Li C.F., and Han Y., 2024, Viral vector-based therapeutic HPV vaccines, Clinical and Experimental Medicine, 24(1): 199. https://doi.org/10.1007/s10238-024-01470-5 Jiang F., 2024, Investigation on the differentiation and functions of immunological memory cells, Journal of Vaccine Research, 14(1): 32-39. https://doi.org/10.5376/jvr.2024.14.0005 Kaczmarczyk K.H., and Yusuf, H., 2021, The impact of HPV vaccination on the prevention of oropharyngeal cancer: a scoping review, Community Dental Health, 39(1): 14-21. https://doi.org/10.1922/CDH_00072Kaczmarczyk08 Kamolratanakul S., and Pitisuttithum P., 2021, Human papillomavirus vaccine efficacy and effectiveness against cancer, Vaccines, 9(12): 1413. https://doi.org/10.3390/vaccines9121413 Kreimer A.R., 2014, Prospects for prevention of HPV-driven oropharynx cancer, Oral Oncology, 50(6): 555-559. https://doi.org/10.1016/j.oraloncology.2013.06.007 Lin K., Roosinovich E., Ma B., Hung C.F, and Wu T.C., 2010, Therapeutic HPV DNA vaccines, Immunologic Research, 47(1-3): 86-112. https://doi.org/10.1007/s12026-009-8141-6
RkJQdWJsaXNoZXIy MjQ4ODYzNA==